TrialCancer chemotherapy and pharmacology2024

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study.

Bin Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.